"The board and management continue to actively engage with strategic parties and potential partners and will assess opportunities as they arise, with interest received in several indications. Cynata seeks to strengthen its commercialisation strategy by advancing clinical development and undertaking further corporate partnering transactions."
I seem to read something along these lines in the last number of quarterlies
Ann: Quarterly Activity Report & Appendix 4C, page-2
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
0.030(12.5%) |
Mkt cap ! $48.50M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 29.5¢ | 26.0¢ | $113.1K | 420.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4999 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 3935 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |